These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1). Hashimoto H; Imamura K; Haruta J; Wakitani K J Med Chem; 2002 Mar; 45(7):1511-7. PubMed ID: 11906292 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series. Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959 [TBL] [Abstract][Full Text] [Related]
5. Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds. Banoglu E; Okçelik B; Kupeli E; Unlü S; Yeşilada E; Amat M; Caturla JF; Sahin MF Arch Pharm (Weinheim); 2003 Jul; 336(4-5):251-7. PubMed ID: 12916060 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design of cyclooxygenase-2 selectivity into ketoprofen. Palomer A; Pascual J; Cabré M; Borràs L; González G; Aparici M; Carabaza A; Cabré F; García ML; Mauleón D Bioorg Med Chem Lett; 2002 Feb; 12(4):533-7. PubMed ID: 11844666 [TBL] [Abstract][Full Text] [Related]
7. COX-1/COX-2 inhibitors based on the methanone moiety. Dannhardt G; Fiebich BL; Schweppenhäuser J Eur J Med Chem; 2002 Feb; 37(2):147-61. PubMed ID: 11858847 [TBL] [Abstract][Full Text] [Related]
8. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors. Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system. Santagati A; Granata G; Marrazzo A; Santagati M Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors. Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938 [TBL] [Abstract][Full Text] [Related]
12. Thalidomide and its analogues as cyclooxygenase inhibitors. Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y Bioorg Med Chem Lett; 2002 Apr; 12(7):1043-6. PubMed ID: 11909713 [TBL] [Abstract][Full Text] [Related]
13. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194 [TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2. Lazer ES; Sorcek R; Cywin CL; Thome D; Possanza GJ; Graham AG; Churchill L Bioorg Med Chem Lett; 1998 May; 8(10):1181-6. PubMed ID: 9871731 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological testing of Acyl-CoA-ketoprofen conjugates as selective irreversible inhibitors of COX-2. Levoin N; Chrétien F; Lapicque F; Chapleur Y Bioorg Med Chem; 2002 Mar; 10(3):753-7. PubMed ID: 11814865 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles. Ranatunge RR; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Young DV; Zemetseva IS Bioorg Med Chem; 2004 Mar; 12(6):1357-66. PubMed ID: 15018908 [TBL] [Abstract][Full Text] [Related]
17. 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors. Friesen RW; Brideau C; Chan CC; Charleson S; Deschênes D; Dubé D; Ethier D; Fortin R; Gauthier JY; Girard Y; Gordon R; Greig GM; Riendeau D; Savoie C; Wang Z; Wong E; Visco D; Xu LJ; Young RN Bioorg Med Chem Lett; 1998 Oct; 8(19):2777-82. PubMed ID: 9873621 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A Bioorg Med Chem Lett; 2003 Feb; 13(4):657-60. PubMed ID: 12639552 [TBL] [Abstract][Full Text] [Related]
19. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors. Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 4,5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity. Habeeb AG; Praveen Rao PN; Knaus EE J Med Chem; 2001 Aug; 44(18):2921-7. PubMed ID: 11520200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]